Biotech

All Articles

Former Seagen chief executive officer unveils new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was marketed to Pfizer in 2015 for a whopping $43...

Ironwood produces further bid for $1B GI medicine with new subgroup records

.On the heels of a period 3 succeed that stopped working to wow financiers, Ironwood Pharmaceuticals...

Novartis inks $150M bargain for autoimmune molecular adhesive

.Do not stop Monte Rosa Therapeutics now. The Boston-based biotech is actually enjoying after signin...

Jade takes exec staff with Chinook vets-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of notable management hirings, shootings and ...

Septerna goes public along with upsized offering of $288M

.Celebrating his business's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer rang t...

AbbVie creates Richter richer, paying out $25M to create invention deal

.AbbVie has come back to the source of its own antipsychotic giant Vraylar in search of an additiona...

GenSight gets into final weeks of cash runway as income flow slips by of reach

.GenSight Biologics is weeks out of losing loan. Once again. The biotech just possesses adequate cas...

AZ licenses disposed of uncommon health condition medication to Monopar Therapeutics

.Monopar Therapeutics is actually recovering a medication coming from the scrap heap of AstraZeneca'...

Arcus' brand new HIF-2a records in kidney cancer mention prospective edge over Merck's Welireg, professionals say

.With new information out on Arcus Biosciences' experimental HIF-2a prevention, one team of experts ...

Roche wagers around $1B to expand Dyno gene therapy delivery contract

.After developing a gene therapy relationship with Dyno Rehabs in 2020, Roche is actually back for a...